The New England journal of medicine, 2022-06, Vol.386 (22), p.2071-2083
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma
- Ist Teil von
- The New England journal of medicine, 2022-06, Vol.386 (22), p.2071-2083
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Quelle
- Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
- Beschreibungen/Notizen
- Among patients with moderate-to-severe asthma who were receiving a range of inhaled glucocorticoid maintenance therapies, the risk of severe asthma exacerbation was significantly lower with as-needed use of a fixed-dose combination of 180 μg of albuterol and 160 μg of budesonide than with albuterol alone.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2203163Titel-ID: cdi_proquest_journals_2672363898
- Format
- –
- Schlagworte
- Administration, Inhalation, Adolescent, Adolescent Medicine, Adult, Age, Albuterol - administration & dosage, Albuterol - adverse effects, Albuterol - therapeutic use, Allergy, Asthma, Asthma - drug therapy, Budesonide, Budesonide - administration & dosage, Budesonide - adverse effects, Budesonide - therapeutic use, Child, Child, Preschool, Clinical Medicine, Clinical Medicine General, Critical Care, Disease prevention, Double-Blind Method, Drug Combinations, Ethanolamines - therapeutic use, FDA approval, Formoterol Fumarate - therapeutic use, Glucocorticoids, Glucocorticoids - administration & dosage, Glucocorticoids - adverse effects, Glucocorticoids - therapeutic use, Humans, Immunology, Inhalers, Maintenance Chemotherapy, Nebulizers and Vaporizers, Outpatient-Based Clinical Medicine, Pediatrics, Pediatrics General, Pulmonary, Quality of life, Questionnaires, Symptom Flare Up, Teenagers, Young Adult